A new study found a link between NovoNordisk’s blockbuster drug Ozempic and a reduced risk of Alzheimer’s disease. 23andMe, ...

IN AN INSIGHTFUL session presented at the European Association for the Study of Diabetes (EASD) Annual Meeting 2024, the ...

For GLP-1 treatment in particular, employers “need to make sure the coverage is married with a patient engagement program, ...

Combining Instacart with Foodsmart telenutrition nearly doubled member engagement, delivered clinically significant ...

DehydraTECH-liraglutide and select DehydraTECH-CBD formulations were the top performing blood sugar groups KELOWNA, BC / ACCESSWIRE / October 24, 2024 / Lexaria Bioscience Corp.

The pivotal trial will evaluate the efficacy of the closed-loop insulin device in maintaining optimal blood glucose levels in ...

Semaglutide is a glucagon-like peptide-1 (GLP-1) drug, and is the active agent in Ozempic and its weight-loss cousin, Wegovy.

U.S. health officials are recommending that people 50 and older get a shot against bacteria that can cause pneumonia and ...

The News Agency of Nigeria (NAN) reports that in the region, NCDs are responsible for 37 per cent of all deaths, accounting ...

Following a low-carbohydrate diet raised C-peptide levels, with a greater increase observed in African Americans.

The Danish drugmaker Novo Nordisk argues that semaglutide, the active ingredient in Ozempic and Wegovy, are too complex for ...

The CVS Health® Foundation today announced $1.5 million in new Health Zones funding between Good Samaritan Health Center, Open Hand Atlanta and Uber Health to increase access to comprehensive health ...